GILD’s 2014 sales guidance excludes Sovaldi: http://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210500473.html Gilead provided its full year 2014 guidance, which excludes the impact of Sovaldi product sales… Analysts on the CC starting in 15 minutes will push hard to get some kind of loose Sovaldi guidance, but they may not succeed.